Veridex Completes Acquisition of Immunicon Corporation Assets
01 August 2008 - 10:11PM
PR Newswire (US)
RARITAN, N.J., Aug. 1 /PRNewswire/ -- Veridex, LLC announced today
it has completed its previously announced acquisition of
substantially all of the assets of Immunicon Corporation (OTC:IMMC)
(BULLETIN BOARD: IMMC) and its wholly-owned subsidiaries. The
assets acquired include intellectual property, product inventory
and clinical data as well as all technologies related to the
CellSearch(TM) System, the first diagnostic test to automate the
detection and enumeration of circulating tumor cells (CTCs), cancer
cells that detach from solid tumors and enter the blood stream. The
CellSearch(TM) System is currently cleared for the prognosis and
monitoring of patients with metastatic breast, metastatic
colorectal and metastatic prostate cancer. As part of the
agreement, Veridex also received all technologies related to
Repeat-Free(TM) (RF) Poseidon(TM) Fluorescent In-Situ Hybridization
(FISH) Probes, which are the latest advance in FISH DNA probes.
"This asset purchase ensures the role of CellSearch(TM) in the
future of Veridex," said Ken Berlin, General Manager, Veridex, LLC.
"It underscores our continued commitment to the medical community
and to cancer patients who may benefit from technologies like the
CellSearch(TM) System." Veridex and Immunicon have partnered since
2000 to develop and commercialize novel cancer diagnostic platforms
and products. About Veridex Veridex, LLC, a Johnson & Johnson
company, is an organization dedicated to providing physicians with
high-value in vitro diagnostic oncology products. Veridex's
products may significantly benefit patients through earlier disease
detection and may enable personalized strategies to help improve
patient management and outcomes. For more information, please visit
http://www.veridex.com/. DATASOURCE: Veridex, LLC CONTACT: Media,
Stephanie Fagan, +1-201-572-9581, or Investor, Louise Mehrotra,
+1-732-524-6491, or Stan Panasewicz, +1-732-524-2524, all for
Veridex, LLC Web site: http://www.veridex.com/
Copyright